Zhengye Biotechnology Holding Limited (ZYBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | |
| Cash Flows From Operating Activities | ||
| Net Income | 1,846 | 5,161 |
| Depreciation Amortization | 3,310 | 3,290 |
| Income taxes - deferred | 127 | 74 |
| Accounts receivable | 2,240 | 4,272 |
| Accounts payable and accrued liabilities | -56 | -4,901 |
| Other Working Capital | -134 | -2,820 |
| Other Operating Activity | -1,709 | 1,554 |
| Operating Cash Flow | $5,624 | $6,630 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | N/A | -168 |
| PPE Investments | -1,847 | -872 |
| Purchase Sale Intangibles | -1,943 | -578 |
| Other Investing Activity | -1,943 | -578 |
| Investing Cash Flow | $-3,790 | $-1,618 |
| Cash Flows From Financing Activities | ||
| Change In Short Term Borrowing | 12,347 | 10,989 |
| Dividend Paid | -2,195 | -5,429 |
| Other Financing Activity | -13,183 | -8,172 |
| Financing Cash Flow | $-3,031 | $-2,612 |
| Exchange Rate Effect | 22 | N/A |
| Beginning Cash Position | 3,724 | 1,341 |
| End Cash Position | 2,549 | 3,741 |
| Net Cash Flow | $-1,175 | $2,400 |
| Free Cash Flow | ||
| Operating Cash Flow | 5,624 | 6,630 |
| Capital Expenditure | -1,862 | -1,018 |
| Free Cash Flow | 3,762 | 5,612 |